DYNAMIC CHANGES IN HIGH SENSITIVITY CARDIAC TROPONIN I IN RESPONSE TO ANTHRACYCLINE-BASED CHEMOTHERAPY: A PILOT STUDY FOR THE CARDIAC CARE TRIAL

Philip D. Adamson,Peter Hall,Ninian N. Lang,Iain R. Macpherson,Olga Oikonomidou,Morag Maclean,Steff Lewis,Heather McVicars,David E. Newby,Nicholas L. Mills,Peter Henriksen

DYNAMIC CHANGES IN HIGH SENSITIVITY CARDIAC TROPONIN I IN RESPONSE TO ANTHRACYCLINE-BASED CHEMOTHERAPY: A PILOT STUDY FOR THE CARDIAC CARE TRIAL

2018

Philip D. Adamson
Peter Hall
Ninian N. Lang
Iain R. Macpherson
Olga Oikonomidou
Morag Maclean
Steff Lewis
Heather McVicars
David E. Newby
Nicholas L. Mills
Peter Henriksen

Treatment advances have improved cancer outcomes and shifted interest towards minimising iatrogenic complications. High-sensitivity cardiac troponin I (hs-cTnI) assays accurately quantify very low concentrations of troponin and may allow early detection of anthracycline-related myocyte injury.

Keywords:

Troponin I
Internal medicine
Anthracycline
Chemotherapy
Medicine
Cardiology
Troponin
cardiac troponin
Cancer
myocyte injury
Diabetes mellitus
volume concentration

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations